SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Commercial Services

News in brief

PharmaNet andAnapharm Europe end JV

27-Jan-2011

US CRO PharmaNet and Anapharm Europe have formally ended the bioanalytical services joint venture.

New Jersey-based PharmaNet said the move follows Maria Cruz Caturla’s, Anapharm Europe's majority shareholder, acquisition of its minority interest in the join venture on December 22.

The contract research organisation (CRO) added that both firms will continue to invest in the respective bioanalystical portfolios and will continue to work together on exsiting projects to provide coordinated support as is required.

Anapharm Europe, which is headquartered in Spain, provides bioanalysis services to drug and biopharmaceutical firms at its laboratory in Barcelona.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products